Treatment of acute promyelocytic leukemia in children: arsenic or ATRA.
Ravindranath
Y
Y
Children's Hospital of Michigan and Wayne State University School of Medicine, Detroit, MI 48201, USA. ravi@med.wayne.edu
Gregory
J
J
Feusner
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use*; D012074:Remission Induction; D015996:Survival Rate; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide